Prime Gene Therapeutics Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Prime Gene Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants. (NCT07619183) | Prime Gene Therapeutics Co., Ltd. | 2026-06-04 |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis (NCT07146126) | Prime Gene Therapeutics Co., Ltd. | 2025-09-15 |
| A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults (NCT07013097) | Prime Gene Therapeutics Co., Ltd. | 2025-05-23 |
| A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis (NCT06837233) | Prime Gene Therapeutics Co., Ltd. | 2025-03-12 |
| A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis (NCT06587685) | Prime Gene Therapeutics Co., Ltd. | 2024-03-15 |
Track Prime Gene Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.